비교리스트

 카트 문의
시장보고서
상품코드
1420965

인플루엔자 진단 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2023-2031년)

Influenza Diagnostics Market (Test Type: RT-PCR Tests, Rapid Influenza Diagnostic Tests, Viral Culture, Immunofluorescence Assays, Serological Tests, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
발행일: | 리서치사: Transparency Market Research | 페이지 정보: 영문 172 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

독감 진단 시장 - 보고서의 범위

TMR의 세계 인플루엔자 진단 시장에 대한 보고서는 과거와 현재의 성장 동향과 2023년부터 2031년까지의 예측 기간 동안 시장 지표에 대한 귀중한 통찰력을 얻을 수 있는 기회를 조사했습니다. 이 보고서는 세계 인플루엔자 진단 시장의 수익을 제공합니다. 2017년부터 2031년까지의 기간 중 2023년을 기준 연도로, 2031년을 예측연도로 간주합니다. 이 보고서는 또한 2023년부터 2031년까지 세계 인플루엔자 진단 시장의 복합 연간 성장률(CAGR%)을 제공합니다.

이 보고서는 광범위한 조사를 통해 작성되었으며, 1차 조사에서는 분석가들이 주요 오피니언 리더, 업계 리더 및 오피니언 제조업체를 인터뷰하는 1차 조사, 독감 진단 시장을 이해하기 위해 주요 기업의 제품, 연례 보고서, 보도 자료, 언론 보도 및 주요 문헌 참조를 포함한 2차 조사로 이루어졌습니다. 문헌, 연례 보고서, 보도 자료 및 관련 문서를 참조하여 독감 진단 시장을 이해합니다.

시장 현황
2023년 시장 가치 13억 달러
2031년 시장 가치 20억 달러
CAGR 5.6%

이 보고서는 세계 인플루엔자 진단 시장의 경쟁 환경을 자세히 조사했습니다. 세계 독감 진단 시장에서 활동하는 주요 기업들이 확인되었으며, 각 기업은 다양한 속성 측면에서 프로파일링되었습니다. 기업 개요, 재무 상태, 최근 동향 및 SWOT는 이 보고서에 소개된 세계 독감 진단 시장 기업의 속성입니다.

목차

제1장 서문

제2장 전제조건과 조사 방법

제3장 주요 요약 : 세계 시장

제4장 시장 개요

  • 서론
  • 개요
  • 시장 역학
  • 세계 시장 분석과 예측, 2017년-2031년

제5장 주요 인사이트

  • 병 역학
  • 상환 시나리오
  • COVID-19 감염증 팬데믹이 업계에 미치는 영향

제6장 세계 시장 분석과 예측 : 인플루엔자 바이러스 유형별

  • 서론과 정의
  • 주요 발견과 개발
  • 시장 매출 예측 : 인플루엔자 바이러스 유형별, 2017년-2031년
    • Type A
    • Type B
  • 시장의 매력 분석 : 인플루엔자 바이러스 유형별

제7장 세계 시장 분석과 예측 : 검사 유형별

  • 서론과 정의
  • 주요 발견과 개발
  • 시장 매출 예측 : 검사 유형별, 2017년-2031년
    • RT-PCR 검사
    • 인플루엔자 신속 진단 검사(RIDT)
    • 바이러스 배양
    • 면역 형광 어세이
    • 혈청학적 검사
    • 기타(LAMP, SAMBA 등)
  • 시장의 매력 분석 : 검사 유형별

제8장 세계 시장 분석과 예측 : 제품 유형별

  • 서론과 정의
  • 주요 발견과 개발
  • 시장 매출 예측 : 제품 유형별, 2017년-2031년
    • 키트 및 시약
    • 기기
    • 기타
  • 시장의 매력 분석 : 제품 유형별

제9장 세계 시장 분석과 예측 : 최종사용자별

  • 서론과 정의
  • 주요 발견과 개발
  • 시장 매출 예측 : 최종사용자별, 2017년-2031년
    • 병원
    • 진단센터
    • 기타(학술연구기관 등)
  • 시장의 매력 분석 : 최종사용자별

제10장 세계 시장 분석과 예측 : 지역별

  • 주요 조사 결과
  • 시장 매출 예측 : 지역별
    • 북미
    • 유럽
    • 아시아태평양
    • 라틴아메리카
    • 중동 및 아프리카
  • 시장의 매력 분석 : 지역별

제11장 북미 시장 분석과 예측

제12장 유럽 시장 분석과 예측

제13장 아시아태평양 시장 분석과 예측

제14장 라틴아메리카 시장 분석과 예측

제15장 중동 및 아프리카 시장 분석과 예측

제16장 경쟁 구도

  • 시장 기업 - 경쟁 매트릭스(기업 Tier 및 규모별)
  • 시장 점유율 분석 : 기업별(2022년)
  • 기업 개요
    • 3M
    • Abbott
    • F. Hoffmann-La Roche Ltd.
    • Becton, Dickinson and Company
    • BIOMERIEUX
    • Bio-Rad Laboratories, Inc.
    • Goldsite Diagnostics Inc.
    • Hologic, Inc.
    • DiaSorin SpA
    • Meridian Bioscience, Inc.
    • QuidelOrtho Corporation
    • SA Scientific Ltd.
    • Sekisui Diagnostics
    • Siemens Healthineers
    • Thermo Fisher Scientific
LSH 24.02.15

Influenza Diagnostics Market - Scope of Report

TMR's report on the global influenza diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global influenza diagnostics market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global influenza diagnostics market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the influenza diagnostics market.

Market Snapshot
Market Value in 2023US$ 1.3 Bn
Market Value in 2031US$ 2 Bn
CAGR5.6%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global influenza diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global influenza diagnostics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global influenza diagnostics market.

The report delves into the competitive landscape of the global influenza diagnostics market. Key players operating in the global influenza diagnostics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global influenza diagnostics market profiled in this report.

Key Questions Answered in Global influenza diagnostics Market Report:

  • What is the sales/revenue generated by influenza diagnostics across all regions during the forecast period?
  • What are the opportunities in the global influenza diagnostics market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Influenza Diagnostics Market - Research Objectives and Research Approach

The comprehensive report on the global influenza diagnostics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global influenza diagnostics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global influenza diagnostics market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Influenza Diagnostics Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Influenza Diagnostics Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Disease Epidemiology
  • 5.2. Reimbursement Scenario
  • 5.3. COVID-19 Pandemic Impact on Industry

6. Global Influenza Diagnostics Market Analysis and Forecast, by Flu Virus Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Flu Virus Type, 2017-2031
    • 6.3.1. Type A
    • 6.3.2. Type B
  • 6.4. Market Attractiveness Analysis, by Flu Virus Type

7. Global Influenza Diagnostics Market Analysis and Forecast, by Test Type

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Test Type, 2017-2031
    • 7.3.1. RT-PCR Tests
    • 7.3.2. Rapid Influenza Diagnostic Tests (RIDTs)
    • 7.3.3. Viral Culture
    • 7.3.4. Immunofluorescence Assays
    • 7.3.5. Serological Tests
    • 7.3.6. Others (LAMP, SAMBA, etc.)
  • 7.4. Market Attractiveness Analysis, by Test Type

8. Global Influenza Diagnostics Market Analysis and Forecast, by Product Type

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by Product Type, 2017-2031
    • 8.3.1. Kits & Reagents
    • 8.3.2. Instrument
    • 8.3.3. Others
  • 8.4. Market Attractiveness Analysis, by Product Type

9. Global Influenza Diagnostics Market Analysis and Forecast, by End-user

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast, by End-user, 2017-2031
    • 9.3.1. Hospitals
    • 9.3.2. Diagnostic Centers
    • 9.3.3. Others (academics & research institutes, etc.)
  • 9.4. Market Attractiveness Analysis, by End-user

10. Global Influenza Diagnostics Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness Analysis, by Region

11. North America Influenza Diagnostics Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Flu Virus Type, 2017-2031
    • 11.2.1. Type A
    • 11.2.2. Type B
  • 11.3. Market Value Forecast, by Test Type, 2017-2031
    • 11.3.1. RT-PCR Tests
    • 11.3.2. Rapid Influenza Diagnostic Tests (RIDTs)
    • 11.3.3. Viral Culture
    • 11.3.4. Immunofluorescence Assays
    • 11.3.5. Serological Tests
    • 11.3.6. Others (LAMP, SAMBA, etc.)
  • 11.4. Market Value Forecast, by Product Type, 2017-2031
    • 11.4.1. Kits & Reagents
    • 11.4.2. Instrument
    • 11.4.3. Others
  • 11.5. Market Value Forecast, by End-user, 2017-2031
    • 11.5.1. Hospitals
    • 11.5.2. Diagnostic Centers
    • 11.5.3. Others (academics & research institutes, etc.)
  • 11.6. Market Value Forecast, by Country, 2017-2031
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Flu Virus Type
    • 11.7.2. By Test Type
    • 11.7.3. By Product Type
    • 11.7.4. By End-user
    • 11.7.5. By Country

12. Europe Influenza Diagnostics Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Flu Virus Type, 2017-2031
    • 12.2.1. Type A
    • 12.2.2. Type B
  • 12.3. Market Value Forecast, by Test Type, 2017-2031
    • 12.3.1. RT-PCR Tests
    • 12.3.2. Rapid Influenza Diagnostic Tests (RIDTs)
    • 12.3.3. Viral Culture
    • 12.3.4. Immunofluorescence Assays
    • 12.3.5. Serological Tests
    • 12.3.6. Others (LAMP, SAMBA, etc.)
  • 12.4. Market Value Forecast, by Product Type, 2017-2031
    • 12.4.1. Kits & Reagents
    • 12.4.2. Instrument
    • 12.4.3. Others
  • 12.5. Market Value Forecast, by End-user, 2017-2031
    • 12.5.1. Hospitals
    • 12.5.2. Diagnostic Centers
    • 12.5.3. Others (academics & research institutes, etc.)
  • 12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Spain
    • 12.6.5. Italy
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Flu Virus Type
    • 12.7.2. By Test Type
    • 12.7.3. By Product Type
    • 12.7.4. By End-user
    • 12.7.5. By Country/Sub-region

13. Asia Pacific Influenza Diagnostics Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Flu Virus Type, 2017-2031
    • 13.2.1. Type A
    • 13.2.2. Type B
  • 13.3. Market Value Forecast, by Test Type, 2017-2031
    • 13.3.1. RT-PCR Tests
    • 13.3.2. Rapid Influenza Diagnostic Tests (RIDTs)
    • 13.3.3. Viral Culture
    • 13.3.4. Immunofluorescence Assays
    • 13.3.5. Serological Tests
    • 13.3.6. Others (LAMP, SAMBA, etc.)
  • 13.4. Market Value Forecast, by Product Type, 2017-2031
    • 13.4.1. Kits & Reagents
    • 13.4.2. Instrument
    • 13.4.3. Others
  • 13.5. Market Value Forecast, by End-user, 2017-2031
    • 13.5.1. Hospitals
    • 13.5.2. Diagnostic Centers
    • 13.5.3. Others (academics & research institutes, etc.)
  • 13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Flu Virus Type
    • 13.7.2. By Test Type
    • 13.7.3. By Product Type
    • 13.7.4. By End-user
    • 13.7.5. By Country/Sub-region

14. Latin America Influenza Diagnostics Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Flu Virus Type, 2017-2031
    • 14.2.1. Type A
    • 14.2.2. Type B
  • 14.3. Market Value Forecast, by Test Type, 2017-2031
    • 14.3.1. RT-PCR Tests
    • 14.3.2. Rapid Influenza Diagnostic Tests (RIDTs)
    • 14.3.3. Viral Culture
    • 14.3.4. Immunofluorescence Assays
    • 14.3.5. Serological Tests
    • 14.3.6. Others (LAMP, SAMBA, etc.)
  • 14.4. Market Value Forecast, by Product Type, 2017-2031
    • 14.4.1. Kits & Reagents
    • 14.4.2. Instrument
    • 14.4.3. Others
  • 14.5. Market Value Forecast, by End-user, 2017-2031
    • 14.5.1. Hospitals
    • 14.5.2. Diagnostic Centers
    • 14.5.3. Others (academics & research institutes, etc.)
  • 14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Flu Virus Type
    • 14.7.2. By Test Type
    • 14.7.3. By Product Type
    • 14.7.4. By End-user
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa Influenza Diagnostics Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Flu Virus Type, 2017-2031
    • 15.2.1. Type A
    • 15.2.2. Type B
  • 15.3. Market Value Forecast, by Test Type, 2017-2031
    • 15.3.1. RT-PCR Tests
    • 15.3.2. Rapid Influenza Diagnostic Tests (RIDTs)
    • 15.3.3. Viral Culture
    • 15.3.4. Immunofluorescence Assays
    • 15.3.5. Serological Tests
    • 15.3.6. Others (LAMP, SAMBA, etc.)
  • 15.4. Market Value Forecast, by Product Type, 2017-2031
    • 15.4.1. Kits & Reagents
    • 15.4.2. Instrument
    • 15.4.3. Others
  • 15.5. Market Value Forecast, by End-user, 2017-2031
    • 15.5.1. Hospitals
    • 15.5.2. Diagnostic Centers
    • 15.5.3. Others (academics & research institutes, etc.)
  • 15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Flu Virus Type
    • 15.7.2. By Test Type
    • 15.7.3. By Product Type
    • 15.7.4. By End-user
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (by tier and size of companies)
  • 16.2. Market Share Analysis, by Company (2022)
  • 16.3. Company Profiles
    • 16.3.1. 3M
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Abbott
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. F. Hoffmann-La Roche Ltd.
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Becton, Dickinson and Company
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. BIOMERIEUX
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. Bio-Rad Laboratories, Inc.
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. Goldsite Diagnostics Inc.
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Hologic, Inc.
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. DiaSorin S.p.A.
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. Meridian Bioscience, Inc.
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Product Portfolio
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview
    • 16.3.11. QuidelOrtho Corporation
      • 16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.11.2. Product Portfolio
      • 16.3.11.3. Financial Overview
      • 16.3.11.4. SWOT Analysis
      • 16.3.11.5. Strategic Overview
    • 16.3.12. SA Scientific Ltd.
      • 16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.12.2. Product Portfolio
      • 16.3.12.3. Financial Overview
      • 16.3.12.4. SWOT Analysis
      • 16.3.12.5. Strategic Overview
    • 16.3.13. Sekisui Diagnostics
      • 16.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.13.2. Product Portfolio
      • 16.3.13.3. Financial Overview
      • 16.3.13.4. SWOT Analysis
      • 16.3.13.5. Strategic Overview
    • 16.3.14. Siemens Healthineers
      • 16.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.14.2. Product Portfolio
      • 16.3.14.3. Financial Overview
      • 16.3.14.4. SWOT Analysis
      • 16.3.14.5. Strategic Overview
    • 16.3.15. Thermo Fisher Scientific
      • 16.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.15.2. Product Portfolio
      • 16.3.15.3. Financial Overview
      • 16.3.15.4. SWOT Analysis
      • 16.3.15.5. Strategic Overview
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제